Top Markets
#1 TENDIES TENDIES +83.50%
#2 Akedo Akedo +81.98%
#3 Verus Coin Verus Coin +43.84%
#4 Threshold Network Threshold Network +43.77%
#5 MultiversX MultiversX +34.16%
#6 Mubarak Mubarak +31.37%
#7 Cash Cat Cash Cat +25.34%
#8 Wrapped Aave Ethereum USDC Wrapped Aave Ethereum USDC +18.00%
#9 Bitway Bitway +16.42%
#10 OSK OSK +16.18%
Coin of the day
TENDIES TENDIES
Settings
Language
ENGLISH
Currency
USD
Theme
Atrys Health, S.A. Atrys Health, S.A.

Atrys Health, S.A.

ATRY
Rank in Stocks #17814
Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in... Atrys Health, S.A., a biomedical enterprise founded in 2007 and based in Madrid, Spain, specializes in providing a range of diagnostic services and medical treatments. Its diagnostic portfolio encompasses areas like pathology, hematology, molecular pathology, and genetics, supplemented by offerings such as diagnostic second opinions, a comprehensive test directory, and support for clinical trials and research & development. The company effectively utilizes telemedicine to deliver its expertise in medical specialties including radiology, cardiology, ophthalmology, and dermatology. Furthermore, Atrys Health administers radiotherapy and is engaged in the development of innovative therapeutic approaches and diagnostic instruments. The organization operated as Althia Health, S.L. before rebranding to Atrys Health, S.A. in May 2016.
Share Price
$2.97
Market Cap
$225.13M
Change (1 day)
-0.99%
Change (1 year)
-9.64%
Country
ES
Trade Atrys Health, S.A. (ATRY)

Category

Healthcare
Revenue for Atrys Health, S.A. (ATRY)
Revenue in Sep 2026 TTM: 0
According to Atrys Health, S.A. latest financial reports the company's current revenue (TTM) is 0. In 2026 the company made a revenue of 0 equal to the revenue in the year 2026 that was 0. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Atrys Health, S.A. from 2026 to 2026
Revenue at the end of each year
Year Revenue Change
Not enough data for the provided dates.
Revenue for similar companies or competitors
Company Revenue Revenue Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $12.62B -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $6.02B -
NL
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $2.23B -
US
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $15.74B -
AU
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH